The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of REFRESH PLUS 0.5% EYE DROPS UD 70S. The contract, valued at $2,510.87, has a completion date of March 1, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies to the Department of Defense through various contract vehicles. This...
The Defense Logistics Agency (DLA) awarded a Firm-Fixed-Price Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of REFRESH PLUS 0.5% EYE DROPS UD 50S medical products. The contract has a ceiling value of $1,683.55 and a period of performance through November 9, 2023. This Delivery Order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S". The contract has a ceiling value of $2,830.94 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of October 18, 2023. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,757.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S" and has a completion date of February 8, 2024. Amerisourcebergen Drug Corp, operating out of its Corporate Office in Conshohocken, Pennsylvania, is the prime contractor on this order, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,564.74, is for the delivery of REFRESH PLUS 0.5% EYE DROPS 30S, a medical supply product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of REFRESH PLUS 0.5% EYE DROPS 30S, a pharmaceutical product, with a potential value of $2,083.68 and a completion date of March 1, 2024. The contract does not have a set-aside designation. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,497.68 firm fixed-price delivery order is for the supply of 4563013620 REFRESH PLUS 0.5% EYE DROPS 30S. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime contractor for this award, and it is a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of REFRESH PLUS 0.5% EYE DROPS UD 70S, a pharmaceutical product, with a ceiling value of $1,675.53 and a completion date of November 27, 2024. This is a firm fixed-price delivery order contract, and there was no set-aside designation used. AmerisourceBergen holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product. The contract is a firm fixed price delivery order with a potential value of $1,525.43 and a completion date of January 19, 2024. No set-aside...
This $1,093.42 firm fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4,561,837,935 units of REFRESH PLUS 0.5% EYE DROPS UD 50S, a prescription ophthalmic product, with a period of performance ending on August 18, 2023. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...